Yeast as a budding technology in target validation

Drug Discovery Today: Technologies

Volumn 1, Issue 2, 2004, Pages 157-162

  Bays, Nathan ^a   Margolis, Jonathan ^a  

^a EXELIXIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMPHOTERICIN; ANTIARRHYTHMIC AGENT; ANTIFUNGAL AGENT; ANTILIPEMIC AGENT; COMPLEMENTARY DNA; METFORMIN; PROTEOME;

CYTOLOGY; DRUG TARGETING; EUKARYOTIC CELL; FUNGAL GENE; GENOMICS; NONHUMAN; PROTEIN DATABASE; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEOMICS; RECEPTOR INTRINSIC ACTIVITY; REVIEW; VALIDATION PROCESS; YEAST;

EID: 13244282959     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2004.09.002     Document Type: Review

References (13)

1. S.C. Huber S.C. Hardin Numerous posttranslational modifications provide opportunities for the intricate regulation of metabolic enzymes at multiple levels Curr. Opin. Plant Biol. 7 2004 318-322
2. W.K. Huh et al. Global analysis of protein localization in budding yeast Nature 425 2003 686-691
3. S. Ghaemmaghami et al. Global analysis of protein expression in yeast Nature 425 2003 737-741
4. G. Ladds et al. Modified yeast cells to investigate the coupling of G protein-coupled receptors to specific G proteins Mol. Microbiol. 47 2003 781-792
5. J. Davey G-protein-coupled receptors: New approaches to maximise the impact of gpcrs in drug discovery Expert Opin. Ther. Targets 8 2004 165-170
6. E. Pajot-Augy et al. Engineered yeasts as reporter systems for odorant detection J. Recept. Signal Transduct. Res. 23 2003 155-171
7. A. Matsumoto et al. Screening for nitric oxide-dependent protein-protein interactions Science 301 2003 657-661
8. G. Giaever et al. Chemogenomic profiling: Identifying the functional interactions of small molecules in yeast Proc. Natl. Acad. Sci. USA 101 2004 793-798
9. G. Giaever A chemical genomics approach to understanding drug action Trends Pharmacol. Sci. 24 2003 444-446
10. G. Giaever et al. Genomic profiling of drug sensitivities via induced haploinsufficiency Nat. Genet. 21 1999 278-283
11. A.H. Tong et al. Systematic genetic analysis with ordered arrays of yeast deletion mutants Science 294 2001 2364-2368
12. A.B. Parsons et al. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways Nat. Biotechnol. 22 2004 62-69
13. T. Hughes et al. Old drugs, new tricks: Using genetically sensitized yeast to reveal drug targets Cell 116 2004 5-7